Lebwohl, M., Kircik, L. ., Moore, A., Stein Gold, L., Del Rosso, J., Draelos, Z., Gooderham, M., Green, L., Herbert, A., Papp, K., Bagel, J. ., Bhatia, N., Ferris, L., Jones, T. ., Kempers, S., Pariser, D., Yamauchi, P., Zirwas, M., Feng, A. ., Burnett, P., Higham, R., & Berk, D. (2021). Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials. SKIN The Journal of Cutaneous Medicine, 5(6), s42. https://doi.org/10.25251/skin.5.supp.42